BR112018003385A2 - peróxido, uso de um peróxido, e formulação para tratamento de pele - Google Patents

peróxido, uso de um peróxido, e formulação para tratamento de pele

Info

Publication number
BR112018003385A2
BR112018003385A2 BR112018003385A BR112018003385A BR112018003385A2 BR 112018003385 A2 BR112018003385 A2 BR 112018003385A2 BR 112018003385 A BR112018003385 A BR 112018003385A BR 112018003385 A BR112018003385 A BR 112018003385A BR 112018003385 A2 BR112018003385 A2 BR 112018003385A2
Authority
BR
Brazil
Prior art keywords
peroxide
skin care
care formulation
linear
carbon atoms
Prior art date
Application number
BR112018003385A
Other languages
English (en)
Other versions
BR112018003385B1 (pt
Inventor
Christian Opsahl Ross
Gina Butuc Steluta
Original Assignee
Akzo Nobel Chemicals Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Chemicals Int Bv filed Critical Akzo Nobel Chemicals Int Bv
Publication of BR112018003385A2 publication Critical patent/BR112018003385A2/pt
Publication of BR112018003385B1 publication Critical patent/BR112018003385B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/327—Peroxy compounds, e.g. hydroperoxides, peroxides, peroxyacids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

em que r1 é selecionado de grupos alquila lineares e ramificados com 1 a 4 átomos de carbono, e em que r2, r3 e r4 são selecionados entre hidrogênio e grupos alquila lineares e ramificados com 1 a 4 átomos de carbono, para uso como um medicamento, em particular para o tratamento de acne.
BR112018003385-5A 2015-08-28 2016-08-25 Formulação para tratamento de pele BR112018003385B1 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201562211060P 2015-08-28 2015-08-28
US62/211,060 2015-08-28
EP15188210 2015-10-02
EP15188210.7 2015-10-02
PCT/EP2016/070036 WO2017036897A1 (en) 2015-08-28 2016-08-25 Formulation for the treatment of acne

Publications (2)

Publication Number Publication Date
BR112018003385A2 true BR112018003385A2 (pt) 2018-09-25
BR112018003385B1 BR112018003385B1 (pt) 2023-08-08

Family

ID=

Also Published As

Publication number Publication date
WO2017036897A1 (en) 2017-03-09
ES2750873T3 (es) 2020-03-27
US10278945B2 (en) 2019-05-07
EP3340975A1 (en) 2018-07-04
CA2996095A1 (en) 2017-03-09
JP6505945B2 (ja) 2019-04-24
US20190321329A1 (en) 2019-10-24
CA2996095C (en) 2023-08-15
JP2018525409A (ja) 2018-09-06
CN107847479B (zh) 2020-11-20
EP3340975B1 (en) 2019-07-24
US20190022050A1 (en) 2019-01-24
PT3340975T (pt) 2019-11-04
CN107847479A (zh) 2018-03-27

Similar Documents

Publication Publication Date Title
CL2017000240A1 (es) Compuestos activos hacia bromodominios
CR20160069A (es) Compuestos terapéuticamente activos y sus métodos de uso
CL2015002567A1 (es) Compuestos y sus usos para modular la hemoglobina
UY35427A (es) Compuestos y sus usos en la modulación de la hemoglobina
CL2015003801A1 (es) Formulaciones de anticuerpos y metodos
UY35425A (es) Compuestos y sus usos en la modulación de la hemoglobina
ECSP15026557A (es) Compuestos y sus métodos de empleo
CR20140388A (es) Compuestos terapeuticamente activos y sus métodos de uso
BR112016025331A2 (pt) composições antimicrobianas
UY35426A (es) Compuestos y sus usos en la modulación de la hemoglobina
PE20151495A1 (es) Compuestos de pirrolopirimidina como inhibidores de quinasas
TR201904455T4 (tr) Nükleer taşıma modülatörleri olarak 1,2,4-triazoller ve bunların kullanımları.
NI201400120A (es) Inhibidores de diacilglicerol aciltransferasa 2
BRPI1106572B8 (pt) Composições que compreendem um retinoide e um inibidor de nfkb e seus métodos de uso
BR112015006847A2 (pt) um elemento auxiliar de barbeamento ou depilação de contato com a pele que compreende ao menos uma substância sensibilizante termicamente resiliente
CL2018000963A1 (es) Cosmética que tiene bacterias probióticas
BR112019002689A2 (pt) terapia com rapamicina tópica
UY35276A (es) Nuevos compuestos que inhiben la actividad de Lp-PLA2
BR112014006455A2 (pt) alquilamidotiazóis, preparações cosméticas ou dermatológicas com um teor de um ou vários alquilamidotiazóis e uso de um ou vários alquilamidotiazóis
ECSP15013883A (es) Benzamidas
CL2016000544A1 (es) Composición cosmética que comprende 0,0001 a 10% en peso de extracto de guacatonga (casearia sylvestris) y 0,00005 a 10% en peso de extracto de aroeira (schinus terebinthifolius raddi) ambos respecto al peso total de la composición; uso de la composición en la prevención y/o tratamiento de los signos de envejicimiento de la piel; metodo para prevenir y/o tratar los signos de envejecimiento de la piel.
BR112016024630A2 (pt) composição tópica, uso de uma composição tópica e aplicador
UY34773A (es) Ácidos indanoiloxidihidrobenzofuranilacéticos como moduladores de la actividad de gpr40, composiciones que los contienen y sus usos
DOP2016000170A (es) Compuestos derivados de hidroxiformamida y usos del mismo
BR112015031772A2 (pt) composições e métodos para o tratamento da pele

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 25/08/2016, OBSERVADAS AS CONDICOES LEGAIS